4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001998663-26-000002
Chief Operating Officer acquired 4,386 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Prince Joshua S. Chief Operating Officer | 2025-12-31 | Grant or award | +4,386 | $0.56 | $2,468 | 15,249 | D |
Loading xslF345X05/edgardoc.xml…